| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 928616
[patent_doc_number] => 07314926
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-01-01
[patent_title] => 'Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin'
[patent_app_type] => utility
[patent_app_number] => 09/958251
[patent_app_country] => US
[patent_app_date] => 2000-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 34
[patent_no_of_words] => 12616
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/314/07314926.pdf
[firstpage_image] =>[orig_patent_app_number] => 09958251
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/958251 | Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin | Apr 6, 2000 | Issued |
Array
(
[id] => 1071780
[patent_doc_number] => 06841362
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-11
[patent_title] => 'Melanoma differentiation associated gene-7 promoter and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/515369
[patent_app_country] => US
[patent_app_date] => 2000-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 27
[patent_no_of_words] => 22518
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/841/06841362.pdf
[firstpage_image] =>[orig_patent_app_number] => 09515369
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/515369 | Melanoma differentiation associated gene-7 promoter and uses thereof | Feb 28, 2000 | Issued |
Array
(
[id] => 715112
[patent_doc_number] => 07052865
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-30
[patent_title] => 'Identification of genes having a role in the presentation of diabetic nephropathy'
[patent_app_type] => utility
[patent_app_number] => 09/914191
[patent_app_country] => US
[patent_app_date] => 2000-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 8614
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/052/07052865.pdf
[firstpage_image] =>[orig_patent_app_number] => 09914191
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/914191 | Identification of genes having a role in the presentation of diabetic nephropathy | Feb 27, 2000 | Issued |
Array
(
[id] => 475776
[patent_doc_number] => 07227012
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-06-05
[patent_title] => 'Latency-associated regulatory region from Herpesvirus saimiri (HVS)'
[patent_app_type] => utility
[patent_app_number] => 09/913970
[patent_app_country] => US
[patent_app_date] => 2000-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7538
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/227/07227012.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913970
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913970 | Latency-associated regulatory region from Herpesvirus saimiri (HVS) | Feb 17, 2000 | Issued |
| 09/454334 | Activated cation channel of the osteoblast as a mechanism of bone anabolism | Dec 2, 1999 | Abandoned |
Array
(
[id] => 7609941
[patent_doc_number] => 06998245
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-14
[patent_title] => 'Serine protease BSSP5'
[patent_app_type] => utility
[patent_app_number] => 09/856319
[patent_app_country] => US
[patent_app_date] => 1999-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13517
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/998/06998245.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856319
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856319 | Serine protease BSSP5 | Nov 18, 1999 | Issued |
Array
(
[id] => 1269701
[patent_doc_number] => 06653099
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'Plant UDP-glucose dehydrogenase'
[patent_app_type] => B1
[patent_app_number] => 09/429906
[patent_app_country] => US
[patent_app_date] => 1999-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14116
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653099.pdf
[firstpage_image] =>[orig_patent_app_number] => 09429906
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/429906 | Plant UDP-glucose dehydrogenase | Oct 28, 1999 | Issued |
| 09/331645 | NOVEL METHOD FOR TESTING THE DIFFERENTIATION STATUS IN PANCREATIC CELLS OF A MAMMAL | Sep 12, 1999 | Abandoned |
| 09/393844 | METHODS AND COMPOSTIONS FOR USE IN GENE THERAPY FOR TREATMENT OF HEMOPHILIA | Sep 9, 1999 | Abandoned |
Array
(
[id] => 1040481
[patent_doc_number] => 06869779
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-22
[patent_title] => 'Nucleic acid sequence for potentiating the expression of useful gene and method therefor'
[patent_app_type] => utility
[patent_app_number] => 09/763836
[patent_app_country] => US
[patent_app_date] => 1999-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18692
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/869/06869779.pdf
[firstpage_image] =>[orig_patent_app_number] => 09763836
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/763836 | Nucleic acid sequence for potentiating the expression of useful gene and method therefor | Jul 6, 1999 | Issued |
| 09/321247 | INACTIVATION OF HIV CO-RECEPTORS AS THERAPY FOR HIV INFECTION | May 26, 1999 | Abandoned |
Array
(
[id] => 1384828
[patent_doc_number] => 06548301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-15
[patent_title] => 'Retroviral gene transfer vectors'
[patent_app_type] => B2
[patent_app_number] => 09/306417
[patent_app_country] => US
[patent_app_date] => 1999-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10809
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548301.pdf
[firstpage_image] =>[orig_patent_app_number] => 09306417
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/306417 | Retroviral gene transfer vectors | May 5, 1999 | Issued |
Array
(
[id] => 1451339
[patent_doc_number] => 06455681
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'DNA molecules encoding single strand gap response proteins involved in activation of a DNA repair/cell cycle checkpoint pathway'
[patent_app_type] => B1
[patent_app_number] => 09/292858
[patent_app_country] => US
[patent_app_date] => 1999-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 29438
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455681.pdf
[firstpage_image] =>[orig_patent_app_number] => 09292858
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/292858 | DNA molecules encoding single strand gap response proteins involved in activation of a DNA repair/cell cycle checkpoint pathway | Apr 15, 1999 | Issued |
| 09/142997 | SEQUENCES AHEAD OF GENE SM22, VECTORS CONTAINING SAME, AND THERAPEUTICAL USES THEREOF, PARTICULARLY FOR TREATING VASCULAR DISEASES | Jan 10, 1999 | Abandoned |
Array
(
[id] => 760763
[patent_doc_number] => 07011973
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-14
[patent_title] => 'Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells in vivo and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/445201
[patent_app_country] => US
[patent_app_date] => 1998-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 19059
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/011/07011973.pdf
[firstpage_image] =>[orig_patent_app_number] => 09445201
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/445201 | Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells in vivo and uses thereof | Jun 2, 1998 | Issued |
Array
(
[id] => 993547
[patent_doc_number] => 06916646
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-07-12
[patent_title] => 'Enterobacteriaceae fermentation strains'
[patent_app_type] => utility
[patent_app_number] => 08/876132
[patent_app_country] => US
[patent_app_date] => 1997-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4615
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/916/06916646.pdf
[firstpage_image] =>[orig_patent_app_number] => 08876132
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/876132 | Enterobacteriaceae fermentation strains | Jun 22, 1997 | Issued |
Array
(
[id] => 7622257
[patent_doc_number] => 06977244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-20
[patent_title] => 'Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides'
[patent_app_type] => utility
[patent_app_number] => 08/726211
[patent_app_country] => US
[patent_app_date] => 1996-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 15009
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/977/06977244.pdf
[firstpage_image] =>[orig_patent_app_number] => 08726211
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/726211 | Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides | Oct 3, 1996 | Issued |
Array
(
[id] => 724069
[patent_doc_number] => 07045336
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-16
[patent_title] => 'Bacterial delivery system'
[patent_app_type] => utility
[patent_app_number] => 08/711961
[patent_app_country] => US
[patent_app_date] => 1996-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 11634
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/045/07045336.pdf
[firstpage_image] =>[orig_patent_app_number] => 08711961
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/711961 | Bacterial delivery system | Sep 5, 1996 | Issued |
| 08/574194 | INSECTICIDE FOR IMPORTED FIRE ANTS AND OTHER INSECT PESTS | Dec 17, 1995 | Abandoned |
Array
(
[id] => 4401805
[patent_doc_number] => 06171609
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Therapeutic inhibitor of vascular smooth muscle cells'
[patent_app_type] => 1
[patent_app_number] => 8/546794
[patent_app_country] => US
[patent_app_date] => 1995-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 34712
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/171/06171609.pdf
[firstpage_image] =>[orig_patent_app_number] => 546794
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/546794 | Therapeutic inhibitor of vascular smooth muscle cells | Oct 22, 1995 | Issued |